Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation End Products in Patients With Stage III Chronic Kidney Disease

NCT07729683 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DIETARY_SUPPLEMENT: Consumption of wakame

Sponsor

Groupe Hospitalier de la Rochelle Ré Aunis

Collaborators

[object Object]